Acute and chronic effects of hyperglycaemia on glucose metabolism: Implications for the development of new therapies

Diabetic Medicine

Volumn 14, Issue SUPPL. 3, 1997, Pages

  Yki Jarvinen H ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Hexosamines; Insulin resistance; NIDDM; Therapy

Indexed keywords

HEXOSAMINE; INSULIN; METFORMIN; PHLORIZIN; SULFONYLUREA;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POSTPRANDIAL STATE; RAT;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; HEXOSAMINES; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; POSTPRANDIAL PERIOD;

EID: 0030837470     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199708)14:3+3.0.CO;2-6     Document Type: Article

References (43)

1. Gerich JE, Mitrakou A, Kelley D, Mandarino L, Nurjhan N, Reilly J, et al. Contribution of impaired muscle glucose clearance to reduced postabsorptive systemic glucose clearance in NIDDM. Diabetes 1990; 39: 211-216.
2. 11C] glucose uptake and metabolism in the brain of insulin-dependent diabetic subjects. Am J Physiol 1990; 258: E805-E812.
3. Consoli A. Role of liver in pathophysiology of NIDDM. Diabetes Care 1992; 15: 430-441.
4. Yki-Järvinen H. Glucose toxicity. Endocr Rev 1992; 13: 415-431.
5. McMahon M, Marsh H, Rizza R. Comparison of the pattern of postprandial carbohydrate metabolism after ingestion of a glucose drink or a mixed meal. J Clin Endocrinol Metab 1989; 68: 647-653.
6. McMahon M, Marsh HM, Rizza RA. Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM. Diabetes 1989; 38: 291-303.
7. Mitrakou A, Kelley D, Veneman T, Jenssen T, Pangburn T, Reilly T, Gerich J. Contribution of abnormal muscle and liver metabolism to postprandial hyperglycemia in NIDDM. Diabetes 1990; 39: 1381-1390.
8. Dinneen S, Gerich J, Rizza R. Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med 1992; 327: 707-717.
9. Cherrington AD, Stevenson RV, Steiner KE, Davis MA, Myers SR, Adkins BA, et al. Insulin, glucagon, and glucose as regulators of hepatic glucose uptake and production in vivo. Diabetes Metab Rev 1987; 3: 307-332.
10. Firth RG, Bell PM, Rizza RA. Effects of tolazamide and exogenous insulin on insulin action in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1986; 314: 1280-1286.
11. Jackson RA, Hawa IM, Jaspan JB, Sim BM, SiSilvio L, Flatherbe D, et al. Mechanism of metformin action in non-insulin-dependent diabetes. Diabetes 1987; 36: 632-640.
12. Yki-Järvinen H, Helve E, Koivisto VA. Hyperglycemia decreases glucose uptake in type 1 diabetes. Diabetes 1987; 36: 892-896.
13. Rossetti L, Smith D, Shulman GI, Papachristou D, DeFronzo RA. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 1987; 79: 1510-1515.
14. Vuorinen-Markkola H, Koivisto VA, Yki-Järvinen H. Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type 1 diabetic patients. Diabetes 1992; 41: 571-580.
15. DeFronzo RA, Gunnarson R, Björkman O, Olsson M, Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest 1985; 76: 149-155.
16. Yki-Järvinen H, Sahlin K, Ren JM, Koivisto VA. Localization of the rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type 1 diabetic patients. Diabetes 1990; 39: 157-167.
17. Mäkimattila S, Virkamäki A, Malmström R, Utriainen T, Yki-Järvinen H. Insulin resistance in type I diabetes mellitus: a major role for reduced glucose extraction. J Clin Endocrinol Metab 1996; 81: 707-712.
18. Zierath JR, Galuska D, Nolte LA, Thörne A, Smedegaard Kristensen J, et al. Effect of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance. Diabetologia 1994; 37: 270-277.
19. Marshall S, Bacote V, Traxinger RR. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 1991; 266: 4706-4712.
20. Kornfeld R. Studies on L-glutamine D-fructose 6-phosphate amidotransferase. I. Feedback inhibition by uridine diphosphate-N-acetylglucosamine. J Biol Chem 1967; 242: 3135-3141.
21. Hebert LF, Daniels MC, Zhou J, Crook ED, Turner RL, Simmons ST, et al. Overexpression of glutamine:fructose-6-phosphate amidotransferase in skeletal muscle of transgenic mice leads to insulin resistance, J Clin Invest 1996; 98: 930-936.
22. Robinson KA, Weinstein ML, Lindenmayer GE, Buse MC. Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat muscle and liver. Diabetes 1995; 44: 1438-1446.
23. Rossetti L, Hawkins M, Gindi J, Barzilai N. In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. J Clin Invest 1995; 96: 132-140.
24. Yki-Järvinen H, Daniels MC, Virkamäki A, Mäkimattila S, DeFronzo RA, McClain D. Increased glutamine: fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM. Diabetes 1996; 45: 302-307.
25. Haltiwanger RS, Kelly WG, Roquemore EP, Blomberg MA, Dong LL-Y, Kreppel L, Chou T-Y, Hart GW. Glycosylation of nuclear and cytoplasmic proteins is ubiquitous and dynamic. Biochem Soc Trans 1992; 20: 264-269.
26. Dinter A, Berger EG. The regulation of cell- and tissue-specific expression of glycans by glycosyltransferases. Adv Exp Med Biol 1995; 376: 53-82.
27. Hart GW. Glycosylation. Curr Opin Cell Biol 1992; 4: 1017-1023.
28. Baron AD, Zhu J-S, Zhu J-H, Weldon H, Maianu L, Garvey WT. Glucosamine induces insulin resistance in vivo by affecting GLUT4 translocation in skeletal muscle. J Clin Invest 1995; 96: 2792-2801.
29. Revers RR, Kolterman OG, Scarlett JA, Gray RS, Olefsky JM. Lack of in vivo insulin resistance in controlled insulin-dependent, type I, diabetic patients. J Clin Endocrinol Metab 1984; 58: 353-358.
30. Yki-Järvinen H, Koivisto VA. Natural course of insulin resistance in type 1 diabetes. N Engl J Med 1986; 315: 224-230.
31. Beck-Nielsen H, Pedersen O, Lindskov HO. Normalization of insulin sensitivity and the cellular insulin binding during treatment of obese diabetics for one year. Acta Endocrinol 1979; 90: 103-112.
32. Rossetti L, Giaccari A, DeFronzo RA. Glucose toxicity. Diabetes Care 1990; 13: 610-630.
33. Rossetti L, Shulman G, Zawalich W, DeFronzo RA. Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. J Clin Invest 1987; 80: 1037-1044.
34. Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333: 550-554.
35. Puhakainen I, Yki-Järvinen H. Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM. Diabetes 1993; 42: 1694-1699.
36. Saloranta C, Taskinen M, Widén E, Härkönen M, Melander A, Groop L. Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM. Diabetes 1993; 42: 1559-1563.
37. Puhakainen I, Koivisto VA, Yki-Järvinen H. No reduction in total hepatic glucose output by inhibition of gluconeogenesis with ethanol in NIDDM patients. Diabetes 1991; 40: 1319-1327.
38. Kubota M, Virkamäki A, Yki-Järvinen H. Ethanol stimulates glycogenolysis in livers from fed rats. Proc Soc Exp Biol Med 1992; 201: 114-118.
39. Gerich JE. Oral hypoglycemic agents. N Engl J Med 1989; 321: 1231-1245.
40. Yki-Järvinen H, Young AA, Lamkin C, Foley JE. Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest 1987; 79: 1713-1719.
41. Yki-Järvinen H, Helve E, Sane T, Nurjhan N, Taskinen M-R. Insulin inhibition of overnight glucose production and gluconeogenesis from lactate in NIDDM. Am J Physiol 1989; 256: E732-E739.
42. Haltiwanger RS, Blomber MA, Hart GW. Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetyl-glucosamine: polypeptide N-acetyltransferase. J Biol Chem 1992; 267: 9005-9013.
43. Daniels MC, Ciaraldi TP, Nikoulina S, Henry RR, McClain DA. Glutamine:fructose-6-phosphate amidotransferase activity in cultured human skeletal muscle cells: relationship to glucose disposal rate in control and non-insulin-dependent diabetes mellitus subjects and regulation by glucose and insulin. J Clin Invest 1996; 97: 1235-1241.